Compare Moderna, Inc. (MRNA) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Marsh & McLennan Companies, Inc. — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Marsh & McLennan Companies, Inc. trades at $180.6 (market cap $87.77B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 3.7× Moderna, Inc.'s market cap, and Marsh & McLennan Companies, Inc. pays a 2.17% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | MRSH | |
|---|---|---|
Market Cap | $23.60B | $87.77B |
Sector | Health | Financials |
52-Week High | $81.80 | $211.21 |
52-Week Low | $22.36 | $157.32 |
Enterprise Value | $19.70B | $108.61B |
Dividend Yield | — | 2.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →
